{"id":"ropivacaine-0-2-for-peng-block","safety":{"commonSideEffects":[{"rate":null,"effect":"Transient neurological symptoms"},{"rate":null,"effect":"Systemic toxicity (CNS/cardiac) at high doses"},{"rate":null,"effect":"Local tissue irritation"},{"rate":null,"effect":"Hypotension"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Ropivacaine is an amide-type local anesthetic that reversibly inhibits sodium influx through voltage-gated sodium channels in nerve cell membranes. This prevents depolarization and action potential generation in sensory and motor nerves. When administered via PENG (Pericapsular Nerve Group) block, it anesthetizes the nerves supplying the hip joint capsule, providing perioperative analgesia for hip surgery.","oneSentence":"Ropivacaine is a local anesthetic that blocks sodium channels in nerve fibers, preventing the initiation and propagation of action potentials to produce regional anesthesia.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:05:49.089Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Regional anesthesia via PENG block for hip surgery perioperative analgesia"}]},"trialDetails":[{"nctId":"NCT06789367","phase":"PHASE4","title":"The Effect of Dexamethasone Administration Route in PENG Block for Pediatric Hip Surgery","status":"COMPLETED","sponsor":"Poznan University of Medical Sciences","startDate":"2025-02-01","conditions":"Hip Dysplasia, Hip Disease","enrollment":60},{"nctId":"NCT07330999","phase":"NA","title":"Three Variants of the PENG Block With and Without Perineural Adjuvants in Older Adults","status":"RECRUITING","sponsor":"Poznan University of Medical Sciences","startDate":"2026-02-13","conditions":"Hip Osteoarthritis","enrollment":120},{"nctId":"NCT07327372","phase":"NA","title":"PENG Block With Dexmedetomidine in Older Adults","status":"RECRUITING","sponsor":"Poznan University of Medical Sciences","startDate":"2026-02-06","conditions":"Hip Osteoarthritis, Arthropathy of Hip","enrollment":30},{"nctId":"NCT07288983","phase":"NA","title":"PENG Block vs Suprainguinal FICB vs Lumbar ESPB for Analgesia After Hip Surgery","status":"RECRUITING","sponsor":"Poznan University of Medical Sciences","startDate":"2026-02-06","conditions":"Hip Osteoarthritis","enrollment":93},{"nctId":"NCT07180979","phase":"PHASE4","title":"PENG vs L-ESPB With S-ESPB for Analgesia in Total Hip Arthroplasty","status":"NOT_YET_RECRUITING","sponsor":"Poznan University of Medical Sciences","startDate":"2026-03-01","conditions":"Hip Osteoarthritis, Hip Arthropathy, Hip Pain Chronic","enrollment":90},{"nctId":"NCT06789328","phase":"PHASE4","title":"The Effect of Dexamethasone Administration Route on Pain and Inflammatory Response in PENG Block for Total Hip Arthroplasty","status":"COMPLETED","sponsor":"Poznan University of Medical Sciences","startDate":"2025-02-01","conditions":"Osteoarthritis, Hip, Hip Pain Chronic, Hip Arthropathy","enrollment":60},{"nctId":"NCT07023094","phase":"PHASE4","title":"PENG With LFCB vs. ESP Blocks for Pediatric Hip Surgery","status":"RECRUITING","sponsor":"Poznan University of Medical Sciences","startDate":"2025-06-16","conditions":"Hip Disease, Hip Dysplasia, Hip Arthropathy","enrollment":60},{"nctId":"NCT06470334","phase":"PHASE4","title":"Dexamethasone With Ropivacaine for PENG Block in Total Hip Arthroplasty","status":"COMPLETED","sponsor":"Poznan University of Medical Sciences","startDate":"2024-11-07","conditions":"Hip Osteoarthritis, Hip Pain Chronic, Hip Arthritis","enrollment":60},{"nctId":"NCT06470139","phase":"PHASE4","title":"Dexamethasone for PENG Block in Total Hip Arthroplasty","status":"COMPLETED","sponsor":"Poznan University of Medical Sciences","startDate":"2024-08-13","conditions":"Hip Osteoarthritis, Hip Arthropathy, Hip Pain Chronic","enrollment":60},{"nctId":"NCT06083428","phase":"PHASE4","title":"Erector Spinae vs. PENG Block for Total Hip Arthroplasty","status":"COMPLETED","sponsor":"Poznan University of Medical Sciences","startDate":"2023-10-17","conditions":"Hip Arthropathy, Hip Osteoarthritis, Hip Pain Chronic","enrollment":90},{"nctId":"NCT05261009","phase":"PHASE4","title":"PENG Block Versus LP Block for THA Postop Pain","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2022-06-13","conditions":"Pain, Postoperative, Hip Pain Chronic","enrollment":154},{"nctId":"NCT06087549","phase":"PHASE4","title":"PENG Block vs. ESP Block for Pediatric Hip Surgery","status":"COMPLETED","sponsor":"Poznan University of Medical Sciences","startDate":"2023-10-17","conditions":"Hip Dysplasia, Hip Injuries, Hip Fractures","enrollment":90},{"nctId":"NCT06086483","phase":"PHASE4","title":"Pain Management After Adductor Canal Block for Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Poznan University of Medical Sciences","startDate":"2020-06-18","conditions":"Knee Osteoarthritis, Knee Arthritis, Knee Arthropathy","enrollment":361},{"nctId":"NCT05721924","phase":"PHASE4","title":"Comparing The Effectiveness Of Pericapsular Nerve Group (PENG) Block Versus Supra-Inguinal Fascia Iliaca Compartment Block(S-FICB) In Reducing Positional Pain During Neuraxial Anaesthesia In Hip Fractures Patients","status":"UNKNOWN","sponsor":"National University of Malaysia","startDate":"2022-12-01","conditions":"Hip Fractures","enrollment":40},{"nctId":"NCT05320913","phase":"NA","title":"Pericapsular Nerve Group (PENG) Block Combined With Periarticular Multimodal Drug Injection (PMDI) Versus Isolated PMDI for Pain Management After Total Hip Arthroplasty: a Randomized Controlled Trial","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2022-04-04","conditions":"Total Hip Arthroplasty, Postoperative Pain","enrollment":58},{"nctId":"NCT04426045","phase":"NA","title":"Pericapsular Nerve Group (PENG) Block Versus Supra-inguinal Fascia Iliaca Compartment Block for Pain Management After Total Hip Arthroplasty: a Randomized Controlled Trial","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2020-07-21","conditions":"Total Hip Arthroplasty, Postoperative Pain","enrollment":58}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":9,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Ropivacaine 0.2% for PENG Block","genericName":"Ropivacaine 0.2% for PENG Block","companyName":"Poznan University of Medical Sciences","companyId":"poznan-university-of-medical-sciences","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ropivacaine is a local anesthetic that blocks sodium channels in nerve fibers, preventing the initiation and propagation of action potentials to produce regional anesthesia. Used for Regional anesthesia via PENG block for hip surgery perioperative analgesia.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}